FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Hahnel, PS; Thaler, S; Antunes, E et al.
Targeting AKT signaling sensitizes cancer to cellular immunotherapy.Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906
Stolz, C; Hess, G; Hahnel, PS et al.
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis.Blood. Bd. 112. H. 8. 2008 S. 3312-21
Storr, MA; Keenan, CM; Emmerdinger, D et al.
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.J Mol Med. Bd. 86. H. 8. 2008 S. 925-36
Klugmann, M; Szumlinski, KK
Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies.Behav Pharmacol. Bd. 19. H. 5-6. 2008 S. 485-500
Hadaschik, BA; Ettinger, S; Sowery, RD et al.
Targeting prostate cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlinInt J Cancer. Bd. 122. H. 10. 2008 S. 2368-2376
Lausch, E; Hermanns, P; Farin, HF et al.
TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndromeAm J Hum Genet. Bd. 83. H. 5. 2008 S. 649-55
Weiss, C; Faust, D; Schreck, I et al.
TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin AOncogene. Bd. 27. H. 15. 2008 S. 2198-207
Rink, A; Lewis, DF; Varma, S et al.
Temperature and hydration effects on absorbance spectra and radiation sensitivity of a radiochromic medium.Med Phys. Bd. 35. H. 10. 2008 S. 4545-55
Spix, C; Eletr, D; Blettner, M et al.
Temporal trends in the incidence rate of childhood cancer in Germany 1987-2004Int J Cancer. Bd. 122. H. 8. 2008 S. 1859-1867
Krämer, I
Temsirolimus - der erste zur antineoplastischen Therapie zugelassene mTOR-AntagonistKrankenhauspharmazie. Bd. 2. 2008 S. 55-60